ReP USP - Resultado da busca

Artigo de periodico
Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin (2024)
Richter, Luca Maurice ; Al-Gousous, Jozef ; Araujo, Gabriel Lima Barros de ; Davies, Neal M ; Löbenberg, Raimar
Source: Journal of Drug Delivery Science and Technology. Unidade: FCF
Subjects: DEPRESSÃO, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RICHTER, Luca Maurice et al. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin. Journal of Drug Delivery Science and Technology, v. 92, p. 1-14, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jddst.2023.105305. Acesso em: 10 nov. 2024.
APA
Richter, L. M., Al-Gousous, J., Araujo, G. L. B. de, Davies, N. M., & Löbenberg, R. (2024). Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin. Journal of Drug Delivery Science and Technology, 92, 1-14. doi:10.1016/j.jddst.2023.105305
NLM
Richter LM, Al-Gousous J, Araujo GLB de, Davies NM, Löbenberg R. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 92 1-14.[citado 2024 nov. 10 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105305
Vancouver
Richter LM, Al-Gousous J, Araujo GLB de, Davies NM, Löbenberg R. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 92 1-14.[citado 2024 nov. 10 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105305
Artigo de periodico
Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions (2022)
Silva, Daniela Amaral ; Davies, Neal M; Bou-Chacra, Nadia Araci ; Ferraz, Humberto Gomes ; Löbenberg, Raimar
Source: Dissolution Technologies. Unidade: FCF
Subjects: TRATO GASTROINTESTINAL, FARMACOCINÉTICA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, v. 29, n. 2, p. 62-75, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P62. Acesso em: 10 nov. 2024.
APA
Silva, D. A., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2022). Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, 29( 2), 62-75. doi:10.14227/DT290222P62
NLM
Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 nov. 10 ] Available from: https://doi.org/10.14227/DT290222P62
Vancouver
Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 nov. 10 ] Available from: https://doi.org/10.14227/DT290222P62
Artigo de periodico
A BCS-based biowaiver approach using biphasic dissolution test (2021)
Silva, Daniela Amaral; Melo, Katherine Jasmine Curo; Davies, Neal M; Bou-Chacra, Nadia Araci ; Ferraz, Humberto Gomes ; Löbenberg, Raimar
Source: Dissolution Technology. Unidade: FCF
Subjects: BIOEQUIVALÊNCIA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, v. 28, n. 4, p. 40-48, 2021Tradução . . Disponível em: https://doi.org/10.14227/DT280421P40. Acesso em: 10 nov. 2024.
APA
Silva, D. A., Melo, K. J. C., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2021). A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, 28( 4), 40-48. doi:10.14227/DT280421P40
NLM
Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 nov. 10 ] Available from: https://doi.org/10.14227/DT280421P40
Vancouver
Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 nov. 10 ] Available from: https://doi.org/10.14227/DT280421P40
Artigo de periodico
Biphasic dissolution as an exploratory method during early drug product development (2020)
Silva, Daniela Amaral; Gousous, Jozef Al; Davies, Neal M; Bou-Chacra, Nadia Araci ; Webster, Gregory K; Lipka, Elke; Amidon, Gordon L; Löbenberg, Raimar
Source: Pharmaceutics. Unidade: FCF
Subjects: ANTI-INFLAMATÓRIOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Biphasic dissolution as an exploratory method during early drug product development. Pharmaceutics, v. 12, p. 1-17 art, 2020Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics12050420. Acesso em: 10 nov. 2024.
APA
Silva, D. A., Gousous, J. A., Davies, N. M., Bou-Chacra, N. A., Webster, G. K., Lipka, E., et al. (2020). Biphasic dissolution as an exploratory method during early drug product development. Pharmaceutics, 12, 1-17 art. doi:10.3390/pharmaceutics12050420
NLM
Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon GL, Löbenberg R. Biphasic dissolution as an exploratory method during early drug product development [Internet]. Pharmaceutics. 2020 ; 12 1-17 art.[citado 2024 nov. 10 ] Available from: https://doi.org/10.3390/pharmaceutics12050420
Vancouver
Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon GL, Löbenberg R. Biphasic dissolution as an exploratory method during early drug product development [Internet]. Pharmaceutics. 2020 ; 12 1-17 art.[citado 2024 nov. 10 ] Available from: https://doi.org/10.3390/pharmaceutics12050420
Artigo de periodico
Mechanistic understanding of underperforming enteric coated products: opportunities to add clinical relevance to the dissolution test (2020)
Silva, Daniela Amaral; Davies, Neal M; Doschak, Michael R; Al-Gousous, Jozef; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Source: Journal of Controlled Release. Unidade: FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Mechanistic understanding of underperforming enteric coated products: opportunities to add clinical relevance to the dissolution test. Journal of Controlled Release, v. 325, p. 23-334, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jconrel.2020.06.031. Acesso em: 10 nov. 2024.
APA
Silva, D. A., Davies, N. M., Doschak, M. R., Al-Gousous, J., Bou-Chacra, N. A., & Löbenberg, R. (2020). Mechanistic understanding of underperforming enteric coated products: opportunities to add clinical relevance to the dissolution test. Journal of Controlled Release, 325, 23-334. doi:10.1016/j.jconrel.2020.06.031
NLM
Silva DA, Davies NM, Doschak MR, Al-Gousous J, Bou-Chacra NA, Löbenberg R. Mechanistic understanding of underperforming enteric coated products: opportunities to add clinical relevance to the dissolution test [Internet]. Journal of Controlled Release. 2020 ; 325 23-334.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.jconrel.2020.06.031
Vancouver
Silva DA, Davies NM, Doschak MR, Al-Gousous J, Bou-Chacra NA, Löbenberg R. Mechanistic understanding of underperforming enteric coated products: opportunities to add clinical relevance to the dissolution test [Internet]. Journal of Controlled Release. 2020 ; 325 23-334.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.jconrel.2020.06.031
Artigo de periodico
Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer (2019)
Silva, Daniela Amaral; Gousous, Jozef Al; Davies, Neal M; Bou-Chacra, Nadia Araci ; Webster, Gregory K; Lipka, Elke; Amidon, Gordon; Löbenberg, Raimar
Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: FCF
Subjects: FÁRMACOS, FORMAS FARMACÊUTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer. European Journal of Pharmaceutics and Biopharmaceutics, v. 142, p. 8-19, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2019.06.006. Acesso em: 10 nov. 2024.
APA
Silva, D. A., Gousous, J. A., Davies, N. M., Bou-Chacra, N. A., Webster, G. K., Lipka, E., et al. (2019). Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer. European Journal of Pharmaceutics and Biopharmaceutics, 142, 8-19. doi:10.1016/j.ejpb.2019.06.006
NLM
Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon G, Löbenberg R. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; 142 8-19.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.ejpb.2019.06.006
Vancouver
Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon G, Löbenberg R. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: the hidden role of bicarbonate buffer [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; 142 8-19.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.ejpb.2019.06.006
Artigo de periodico
Application of in silico tools in clinical practice using Ketoconazole as a model drug (2018)
Silva, Daniela Amaral; Duque, Marcelo Dutra; Davies, Neal M; Löbenberg, Raimar; Ferraz, Humberto Gomes
Source: Journal of Pharmacy and Pharmaceutical Sciences. Unidade: FCF
Subjects: ANTIFÚNGICOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Application of in silico tools in clinical practice using Ketoconazole as a model drug. Journal of Pharmacy and Pharmaceutical Sciences, v. 21, n. 1s, p. 242s-253s, 2018Tradução . . Disponível em: https://www.ncbi.nlm.nih.gov/pubmed/30348250. Acesso em: 10 nov. 2024.
APA
Silva, D. A., Duque, M. D., Davies, N. M., Löbenberg, R., & Ferraz, H. G. (2018). Application of in silico tools in clinical practice using Ketoconazole as a model drug. Journal of Pharmacy and Pharmaceutical Sciences, 21( 1s), 242s-253s. Recuperado de https://www.ncbi.nlm.nih.gov/pubmed/30348250
NLM
Silva DA, Duque MD, Davies NM, Löbenberg R, Ferraz HG. Application of in silico tools in clinical practice using Ketoconazole as a model drug [Internet]. Journal of Pharmacy and Pharmaceutical Sciences. 2018 ; 21( 1s): 242s-253s.[citado 2024 nov. 10 ] Available from: https://www.ncbi.nlm.nih.gov/pubmed/30348250
Vancouver
Silva DA, Duque MD, Davies NM, Löbenberg R, Ferraz HG. Application of in silico tools in clinical practice using Ketoconazole as a model drug [Internet]. Journal of Pharmacy and Pharmaceutical Sciences. 2018 ; 21( 1s): 242s-253s.[citado 2024 nov. 10 ] Available from: https://www.ncbi.nlm.nih.gov/pubmed/30348250

USP Schools

ReP

Filtros

Authors

Date published

Subjects

Source title

Non normalized affiliation